Home
Conditions
Mycosis Fungoides

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

307 public trials 30 recruiting studies

Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Completed

Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer

NCT01164709

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Congenital Abnormalities, +42 more
Locations: Inselspital Bern Bern, Switzerland

Kantonsspital Graubuenden Chur, Switzerland

Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland

Kantonsspital - St. Gallen Sankt Gallen, Switzerland

View Trial Details

Completed

Alemtuzumab in Treating Patients With Relapsed or Refractory Advanced Mycosis Fungoides or Sézary Syndrome

NCT00057967

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Northwestern University, Northwestern Medical Faculty Foundation Chicago, Illinois, United States

Veterans Affairs Medical Center - Lakeside Chicago Chicago, Illinois, United States

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides

NCT00103246

Conditions: Carcinoma, Carcinoma, Basal Cell, Hemic and Lymphatic Diseases, +23 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

NCT00005639

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

NCT00038025

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Cutaneous T-Cell Lymphoma, +22 more
Locations: M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

PUVA Maintenance Therapy in Mycosis Fungoides

NCT01686594

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Medical University of Graz Graz, Austria

Department of Dermatology, Medical University of Innsbruck Innsbruck, Austria

Department of Dermatology, General Hospital of the City of Linz Linz, Austria

Department of Dermatology, Hospital Salzburg - Paracelsus Private Medical University Salzburg, Austria

View Trial Details

Completed

Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies

NCT00038376

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +12 more
Locations: M. D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Romidepsin, Ifosfamide, Carboplatin, and Etoposide in Treating Participants With Relapsed or Refractory Peripheral T-Cell Lymphoma

NCT01590732

Conditions: Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Mycosis Fungoides

Mycosis Fungoides trial results

Related conditions